FdaApplication
ANDA 208327
Identifiers
- fda_app_no: ANDA208327
Properties
| Property | Value |
|---|---|
| applicant_name | AMNEAL PHARMACEUTICALS OF NEW YORK LLC |
| application_type | ANDA |
| approval_date | 2019-01-07 |
Products (2)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| ABIRATERONE ACETATE | ABIRATERONE ACETATE | 500MG | TABLET;ORAL |
| ABIRATERONE ACETATE | ABIRATERONE ACETATE | 250MG | TABLET;ORAL |
2 products